X. Cynthia

Also affiliated with Washington University in St. Louis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.4Author DataRank

Indexed papers

11in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 11 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 66 papers — median percentile 0. Top paper: “Proteogenomic integration reveals therapeutic targets in breast cancer xenografts”.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms14864

N/A

4.9DataRank · unranked

155 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3

Top 8%

2.7DataRank

Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Annals of Oncology(2023)10.1016/j.annonc.2023.08.003

N/A

1.4DataRank · unranked

61 citations

L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more

Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724)

Supportive Care in Cancer(2020)10.1007/s00520-020-05543-5

N/A

1.3DataRank · unranked

38 citations

Travis Dockter, Eric Wolfe, Jennifer Le‐Rademacher, Nina D. Wagner‐Johnston, Lawrence H. Einhorn +8 more

Integrative omics analyses broaden treatment targets in human cancer

Genome Medicine(2018)10.1186/s13073-018-0564-z

N/A

1.2DataRank · unranked

26 citations

Sam Qiancheng Sun, Kuan-lin Huang, Clara Oh, Matthew H. Bailey, Rajees Varghese +16 more

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06307-3

N/A

1.1DataRank · unranked

35 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

EBioMedicine(2022)10.1016/j.ebiom.2022.104316

Top 20%

1.0DataRank

Top 20%17 citations

Lorenzo Gerratana, Katherine Clifton, Arielle J. Medford, Marko Velimirovic, Whitney L. Hensing +17 more

KSTAR: An algorithm to predict patient-specific kinase activities from phosphoproteomic data

Nature Communications(2022)10.1038/s41467-022-32017-5

N/A

0.996DataRank · unranked

31 citations

Ben T. Jordan, Hamza Ahmed, X. Cynthia, Kristen M. Naegle, Sam Crowl

Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms15479

N/A

0.843DataRank · unranked

11 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

JAMA Oncology(2024)10.1001/jamaoncol.2023.6038

N/A

0.819DataRank · unranked

21 citations

Vera J. Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A. Marilyn Leitch +25 more

Microscaled proteogenomic methods for precision oncology

Nature Communications(2020)10.1038/s41467-020-14381-2

N/A

0.722DataRank · unranked

122 citations

Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan +28 more

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

npj Breast Cancer(2023)10.1038/s41523-022-00504-z

N/A

0.705DataRank · unranked

23 citations

Donald W. Northfelt, Tracey L. O’Connor, Ellis Levine, Jingqin Luo, Yu Tao +16 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014

Top 31%

0.652DataRank

Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa113

N/A

0.587DataRank · unranked

49 citations

Laura H. Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford A. Hudis +27 more

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

UNC Libraries(2020)10.17615/0xdg-yq72

N/A

0.552DataRank · unranked

6 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer

Nature Communications(2024)10.1038/s41467-024-49875-w

N/A

0.524DataRank · unranked

32 citations

Shuyan Zhou, Yan Kai, Ya-qin Zhang, Changmin Peng, Zhuqing Li +10 more

Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1

Cell Reports(2021)10.1016/j.celrep.2021.108749

N/A

0.483DataRank · unranked

24 citations

Sun-Joong Kim, Arshag D. Mooradian, Faliang Wang, Ziqian Li, Sean Holohan +9 more

A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression

JCO Precision Oncology(2023)10.1200/po.22.00532

N/A

0.425DataRank · unranked

16 citations

Taronish D. Dubash, Gabriela N. Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S.L. Kim +27 more

Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer

medRxiv(2021)10.1101/2021.11.19.21266466

N/A

0.396DataRank · unranked

13 citations

S. Peter Goedegebuure, Nancy B. Myers, Tammi L. Vickery, Michael D. McLellan, Feng Gao +23 more

Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models

Cancers(2020)10.3390/cancers12123857

N/A

0.396DataRank · unranked

13 citations

Tina Primeau, Jingqin Luo, Cynthia Zhang, Hua Sun, Jeremy Hoog +10 more

Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials

Tomography(2023)10.3390/tomography9020053

N/A

0.373DataRank · unranked

11 citations

Cristian T. Badea, Thomas L. Chenevert, Heike E. Daldrup‐Link, Li Ding, Lacey E. Dobrolecki +20 more

A phase I/II trial evaluating the safety and efficacy of eribulin in combination with copanlisib in patients with metastatic triple-negative breast cancer (TNBC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps1128

N/A

0.241DataRank · unranked

4 citations

Leslie Nehring, J. L. Anderson, Brittney Haas, Jingqin Luo, Meghna S. Trivedi +10 more

Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0047

N/A

0.208DataRank · unranked

3 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nikki Fettig +11 more

Molecular characterization of the Ras-MAPK pathway in metastatic breast cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1034

N/A

0.193DataRank · unranked

2 citations

Jun Yin, Joanne Xiu, W. Michael Korn, Heinz‐Josef Lenz, Gino K. In +14 more

Neratinib Synergizes with Trastuzumab Antibody Drug Conjugate or with Vinorelbine to Treat HER2 Mutated Breast Cancer Patient Derived Xenografts and Organoids

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.19.572069

N/A

0.165DataRank · unranked

2 citations

Tina Primeau, Maureen Highkin, Stephanie L. Pratt, Ashley R. Tipton, Nagalaxmi Vemalapally +9 more

Immunogenomic Profiling and Pathological Response Results From a Clinical Trial of Docetaxel and Carboplatin in Triple Negative Breast Cancer

Research Square(2021)10.21203/rs.3.rs-420931/v1

N/A

0.104DataRank · unranked

1 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science–Based Study

JMIR Research Protocols(2022)10.2196/35736

N/A

0DataRank · unranked

5 citations

Uzoma Charles Okere, Graham A. Colditz, X. Cynthia, Jingxia Liu, Courtney Harriss +9 more

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis

Breast Cancer Research(2023)10.1186/s13058-023-01718-0

N/A

0DataRank · unranked

13 citations

Andrew A. Davis, Marko Velimirovic, Katherine Clifton, Whitney L. Hensing, Ami N. Shah +13 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350.v1

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Data from Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets

(2023)10.1158/2326-6066.c.6550521

N/A

0DataRank · unranked

0 citations

Seunghyun Lee, David Clever, Emily Eul, Haley Ellis, X. Cynthia +2 more

O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer

Research Square(2023)10.21203/rs.3.rs-3377962/v1

N/A

0DataRank · unranked

0 citations

Yi Zhang, Shuyan Zhou, Kai Yan, Yaqin Zhang, Changmin Peng +8 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

Cancer-associated fibroblast-derived Dickkopf-1 suppresses NK cell cytotoxicity in breast cancer

Research Square(2024)10.21203/rs.3.rs-4202878/v1

N/A

0DataRank · unranked

1 citations

Seunghyun Lee, Biancamaria Ricci, Jennifer Tran, Jiayu Ye, David Clever +6 more

Microscaled proteogenomic methods for precision oncology

UNC Libraries(2024)10.17615/rb11-7v56

N/A

0DataRank · unranked

0 citations

B Zhang, F. O. Ademuyiwa, Prashant R. Singh, Charles M. Perou, Alexander B. Saltzman +28 more

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

EBioMedicine(2025)10.1016/j.ebiom.2025.105828

N/A

0DataRank · unranked

7 citations

Rosario Chica-Parrado, Caroline Weipert, Todd C. Knepper, Emily Podany, Fabiana Napolitano +21 more

Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB–Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer

Cancer Research(2025)10.1158/0008-5472.can-24-2492

N/A

0DataRank · unranked

6 citations

Yi Zhang, Julie Belmar, Chunyan Hou, Yaqin Zhang, Changmin Peng +12 more

Supplementary Figure S3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976510

Top 100%

0DataRank

Top 100%0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

FIGURE 3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976528

N/A

0DataRank · unranked

0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models

10.1158/2767-9764.25976516

N/A

0DataRank · unranked

0 citations

Jingqin Luo, R. Jay Mashl, Jeremy Hoog, Piyush Maiti, Nicole Fettig +11 more

KSTAR: An algorithm to predict patient-specific kinase activities from phosphoproteomic data

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.06.451378

N/A

0DataRank · unranked

3 citations

Ben T. Jordan, Hamza Ahmed, X. Cynthia, Kristen M. Naegle, Sam Crowl

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416128.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416122

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416116

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416134

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 1 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416131.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416119

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416116.v1

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416140

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416128

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416122.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Additional file 2: of Integrative omics analyses broaden treatment targets in human cancer

Figshare(2018)10.6084/m9.figshare.6874382

Top 100%

0DataRank

Top 100%0 citations

Sam Qiancheng Sun, Kuan-lin Huang, Clara Oh, Matthew H. Bailey, Rajees Varghese +16 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416140.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416134.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2657

N/A

0DataRank · unranked

39 citations

Matthew T. Chang, Dejan Juric, Cristina Saura, Valentina Gambardella, Anton Melnyk +16 more

Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy Using Biomarkers, Ultrasound, and Diffuse Optical Tomography

Research Square(2020)10.21203/rs.3.rs-54759/v1

N/A

0DataRank · unranked

2 citations

Foluso O. Ademuyiwa, Catherine Young, Catherine M. Appleton, Matthew F. Covington, X. Cynthia +9 more

A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients

PLoS ONE(2021)10.1371/journal.pone.0246139

N/A

0DataRank · unranked

23 citations

Chidananda Mudalagiriyappa, X. Cynthia, Jackie Snider, Madhurima Kaushal, Mark A. Watson +2 more

Effective Treatment of Established Bone Metastases Can Be Achieved by Combinatorial Osteoclast Blockade and Depletion of Granulocytic Subsets

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0232

N/A

0DataRank · unranked

19 citations

Seunghyun Lee, David Clever, Emily Eul, Haley Ellis, X. Cynthia +2 more

A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment

PLoS ONE(2021)10.1371/journal.pone.0225869

N/A

0DataRank · unranked

4 citations

Marco Tomasetti, Sekar T. Verapazham, Ramasamy Paulmurugan, X. Cynthia, Sandeep Rajput +3 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416119.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Antipsychotic Drugs and the Risk of Breast Cancer

medRxiv(2021)10.1101/2021.06.06.21258408

N/A

0DataRank · unranked

1 citations

John M. Sahrmann, Margaret A. Olsen, Katelin B. Nickel, J. Philip Miller, X. Cynthia +2 more

Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.19.427299

N/A

0DataRank · unranked

0 citations

Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia +13 more

Evaluation of sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy (NET) and subsequent prognosis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.580

N/A

0DataRank · unranked

0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Proteins in Tumor-Derived Plasma Extracellular Vesicles Indicate Tumor Origin

Molecular & Cellular Proteomics(2022)10.1016/j.mcpro.2022.100476

N/A

0DataRank · unranked

23 citations

Petra Erdmann-Gilmore, Jacqueline L. Mudd, Qiang Zhang, R. W. Seymour, Zhanfang Guo +11 more

X. Cynthia

Indexed papers

Top data-sharing exemplar

Papers